* Inari Medical Inc NARI.OQ reported quarterly adjusted
earnings
of 4 cents per share for the quarter ended in June. The mean
expectation of nine analysts for the quarter was for a loss
of 13 cents per share.
* Revenue rose 28.3% to $119.01 million from a year ago;
analysts
expected $116.63 million.
* Inari Medical Inc's reported EPS for the quarter was 4
cents.
* The mean earnings estimate of analysts had risen by
about 7.9%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Inari Medical Inc shares had fallen by 2.7% this
quarter and
lost 11.0% so far this year.
* The company reported quarterly net income of $2.09
million.
* Wall Street's median 12-month price target for Inari
Medical Inc
is $84.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 2 at 09:02 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.13 0.04 Beat
Mar. 31 2023 -0.23 -0.04 Beat
Dec. 31 2022 -0.17 -0.11 Beat
Sep. 30 2022 -0.25 -0.19 Beat